Newsletter | April 27, 2026

04.27.26 -- Rethinking Drug Delivery: Oral Biologics, CNS Precision, And Beyond

FEATURED EDITORIAL

Enabling Oral Delivery Of Biologics

Videocast host Tom von Gunden talks with CEO Thomas von Erlach from delivery platform developer Vivtex about using high-throughput screening, advanced computational tools, and formulation technologies to drive higher absorption and bioavailability of peptides and other macromolecules delivered via gastrointestinal routes. 

 

Advances In Precision Delivery In CNS Oncology

Plus Therapeutics’ approach combines localized radiotherapy with advanced diagnostics and monitoring to improve outcomes for patients with CNS cancers.

INDUSTRY INSIGHTS

 

Innovating Subcutaneous Delivery Of Large-Volume Complex Biologics

Explore the key findings of a new wearable injector clinical trial, including its positive impact on patient experience and the broader benefits of wearable injectors for chronic disease management.

 

Creating Biologics, GLP-1s For Sub-Q And Inhaled Delivery

Developing new delivery routes is essential for creating more effective treatments. We enable new routes to simplify dosing, enhance patient comfort, and reduce healthcare costs.

 

Complex Manufacturing For Liquid And Lyophilized Drug Products

Aseptic fill and finish operations gain efficiency and precision with modular isolator technology, inline weight checks, and lyophilization, which are ideal for mRNA-LNPs and other sensitive modalities.

 

Roundtable: Fill-Finish Contract Manufacturing Trends

Fill‑finish is evolving as biologics and advanced therapies shift capacity and sterility needs. Automation, emerging tech, and data‑driven methods are boosting efficiency in aseptic production.

 

Antibody-Drug Conjugates: The Chemistry For Attaching Payloads

Review the complexities of developing linkers – chemical moieties which attach a drug payload to an antibody – and considerations when identifying a CRO for ADC research and development.

 

Regulatory, Risk, And Cost Benefits Of New Approach Methodologies (NAMs)

NAMs are transforming risk assessment. Learn how integrating advanced in vitro models and computational tools can improve efficiency, reduce costs, and strengthen regulatory decision-making.

SOLUTIONS

CDMO Fill-Finish And Delivery Services For Pharma